Wolverine Trading, LLC Puma Biotechnology, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 23, 2023	BUY	$2.6 - $3.58 $28,600 - $39,380	11,000 New	11,000 $38,000
Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.3 $19,516 - $39,270	-11,900 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.13 - $3.24 $426 - $648	-200 Reduced 1.65%	11,900 $34,000
Q3 2021 Nov 12, 2021	SELL	$6.63 - $9.39 $10,608 - $15,024	-1,600 Reduced 11.68%	12,100 $85,000
Q2 2021 Aug 06, 2021	BUY	$8.98 - $11.6 $123,026 - $158,920	13,700 New	13,700 $123,000
Q1 2021 May 14, 2021	SELL	$9.38 - $13.63 $186,662 - $271,237	-19,900 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$7.78 - $12.13 $46,680 - $72,780	-6,000 Reduced 23.17%	19,900 $207,000
Q3 2020 Nov 13, 2020	SELL	$9.5 - $11.14 $12,350 - $14,482	-1,300 Reduced 4.78%	25,900 $260,000
Q2 2020 Aug 13, 2020	BUY	$7.01 - $13.24 $12,618 - $23,832	1,800 Added 7.09%	27,200 $278,000
Q1 2020 May 11, 2020	SELL	$6.28 - $14.57 $206,612 - $479,353	-32,900 Reduced 56.43%	25,400 $214,000
Q4 2019 Feb 12, 2020	BUY	$6.5 - $10.73 $112,450 - $185,629	17,300 Added 42.2%	58,300 $490,000
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $114,625 - $168,335	13,100 Added 46.95%	41,000 $458,000
Q2 2019 Aug 20, 2019	SELL	$12.3 - $35.76 $113,160 - $328,992	-9,200 Reduced 24.8%	27,900 $355,000
Q1 2019 May 15, 2019	BUY	$20.77 - $42.37 $461,094 - $940,614	22,200 Added 148.99%	37,100 $1.44 Million
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $28,098 - $65,380	1,400 Added 10.37%	14,900 $314,000
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $247,200 - $359,100	6,000 Added 80.0%	13,500 $619,000
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $268,650 - $446,625	4,500 Added 150.0%	7,500 $510,000
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $140,775 - $198,674	-1,500 Reduced 33.33%	3,000 $297,000
Q3 2017 Nov 15, 2017	BUY	$72.0 - $119.75 $324,000 - $538,875	4,500	4,500 $539,000

Others Institutions Holding PBYI

# of Institutions

101

Shares Held

29M

Call Options Held

50.6K

Put Options Held

16.3K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$10.9 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$10.7 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$9.19 Million
0.42% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.88M
Shares

$8.64 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.91 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $137M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account